The DOI matches its Crossref record; 212 of the 213 references it cites were found in a registry or an index.
Wnt signaling in cancer
Open accessAbstract
Wnt signaling is one of the key cascades regulating development and stemness, and has also been tightly associated with cancer. The role of Wnt signaling in carcinogenesis has most prominently been described for colorectal cancer, but aberrant Wnt signaling is observed in many more cancer entities. Here, we review current insights into novel components of Wnt pathways and describe their impact on cancer development. Furthermore, we highlight expanding functions of Wnt signaling for both solid and liquid tumors. We also describe current findings how Wnt signaling affects maintenance of cancer stem cells, metastasis and immune control. Finally, we provide an overview of current strategies to antagonize Wnt signaling in cancer and challenges that are associated with such approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“β-catenin, a critical mediator of the WNT signaling pathway, plays an important role in tumorigenesis.441–444”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [441]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Mutations affecting segment number and polarity in Drosophila
Nüsslein‐Volhard, C., & Wieschaus, E. F. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370
Flagged first, then by citations
1 of the 213 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Sharma R . Wingless, a new mutant in D. melanogaster. Drosoph Inf Serv 1973; 50: 134.
- Yeung J, Esposito MT, Gandillet A, Zeisig BB, Griessinger E, Bonnet D et al. Beta-catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 2010; 18: 606–618. · DOI
- Luga V, Zhang L, Viloria-Petit AM, Ogunjimi A a, Inanlou MR, Chiu E et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151: 1542–1556. · DOI · Paper page
- van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 2015; 161: 933–945. · DOI · Paper page
Cited by
Sorted by citations
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597
Tumour-intrinsic resistance to immune checkpoint blockade
Kalbasi, A. K., & Ribas, A. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,525
Clara, J., Monge, C., Yang, Y., & Takebe, N. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 768
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
The impact of sex on gene expression across human tissues
Oliva, M., Muñoz-Aguirre, M., Kim-Hellmuth, S., Wucher, V., Gewirtz, A. D., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A., et al. (2020) · Science · doi:10.1126/science.aba3066 · Cited by 697
Fares, C. M., Allen, E. M. V., Drake, C. G., Allison, J. P., & Hu‐Lieskovan, S. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_240837 · Cited by 665
Stem cell programs in cancer initiation, progression, and therapy resistance
Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., Langhe, S. D., & Thannickal, V. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 525
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 540
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
Kröger, C., Afeyan, A. B., Mraz, J., Eaton, E. N., Reinhardt, F., Khodor, Y. L., Thiru, P., Bierie, B., Ye, X., Burge, C. B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812876116 · Cited by 517
The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators
Rim, E. Y., Clevers, H. C., & Nusse, R. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-103615 · Cited by 507
Katoh, M. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4129 · Cited by 478
Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
Yang, Q., Ciebiera, M., Bariani, M. V., Ali, M. K., Elkafas, H., Boyer, T., & Al-Hendy, A. A. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab039 · Cited by 497
Ülgen, E., Özışık, O., & Sezerman, O. U. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00858 · Cited by 471
MYC Deregulation in Primary Human Cancers
Kalkat, M., Melo, J. D., Hickman, K. A., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W. B., & Penn, L. Z. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 469
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
Wang, Y., Zheng, L., Shang, W., Yang, Z., Li, T., Liu, F., Shao, W., Lv, L. L., Chai, L., Qu, L., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01008-w · Cited by 439
Jung, Y., & Park, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 431
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Lei, Q., Wang, D., Sun, K., Wang, L., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00672 · Cited by 431
Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
Bhat, A. A., Uppada, S. B., Achkar, I. W., Hashem, S., Yadav, S. K., Shanmugakonar, M., Al‐Naemi, H. A., Haris, M., & Shahab Uddin, M. S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01942 · Cited by 422
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Mesenchymal stem/stromal cells in cancer therapy
Lan, T., Luo, M., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01208-w · Cited by 374
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
Wnt signaling pathway: A comprehensive review
Hayat, R., Manzoor, M., & Hussain, A. (2022) · Cell Biology International · doi:10.1002/cbin.11797 · Cited by 379
Arora, R., Cao, C., Kumar, M., Sinha, S., Chanda, A., McNeil, R., Samuel, D., Arora, R. K., Matthews, T. W., Chandarana, S. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40271-4 · Cited by 363
Mehta, M., Dhanjal, D. S., Paudel, K. R., Singh, B., Gupta, G., Rajeshkumar, S., Thangavelu, L. P., Tambuwala, M. M., Bakshi, H. A., Chellappan, D. K., et al. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00698-3 · Cited by 334
Tang, B., Yang, Y., Kang, M., Wang, Y., Wang, Y., Bi, Y., He, S., & Shimamoto, F. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1128-6 · Cited by 326
RetractedChen, S., Lin, T., Basu, R., Ritchey, J., Wang, S., Luo, Y., Li, X., Pei, D., Kara, L. B., & Cheng, X. (2024) · Nature Communications · doi:10.1038/s41467-024-45766-2 · Cited by 324
Biomolecular Condensates and Cancer
Boija, A., Klein, I. A., & Young, R. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.003 · Cited by 338
Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression
Huang, D., Wang, Y., Thompson, J. W., Yin, T., Alexander, P. B., Qin, D., Mudgal, P., Wu, H., Liang, Y., Tan, L., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00820-9 · Cited by 323
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Chen, X., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 347
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Zanconato, F., Battilana, G., Forcato, M., Filippi, L., Azzolin, L., Manfrin, A., Quaranta, E. G., Biagio, D. D., Sigismondo, G., Guzzardo, V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0158-8 · Cited by 314
Wnt Pathway in Bone Repair and Regeneration – What Do We Know So Far
Houschyar, K. S., Tapking, C., Borrelli, M. R., Popp, D., Duscher, D., Maan, Z. N., Chelliah, M. P., Li, J., Harati, K., Wallner, C., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00170 · Cited by 306
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Martín‐Orozco, E., Sanchez-Fernandez, A., Ortiz-Parra, I., & Nicolás, M. A.-S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02854 · Cited by 306
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Patel, S., Alam, A., Pant, R., & Chattopadhyay, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02872 · Cited by 293
Zhang, C., Zhang, M., Ge, S., Huang, W., Lin, X., Gao, J. X., Gong, J., & Shen, L. (2019) · Cancer Medicine · doi:10.1002/cam4.2360 · Cited by 283
Long-term and sequential treatment for osteoporosis
Foessl, I., Dimai, H. P., & Obermayer-Pietsch, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00866-9 · Cited by 273
Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J. J., Guha, C., & Dwarakanath, B. S. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650772 · Cited by 275
WNT as a Driver and Dependency in Cancer
Parsons, M. J., Tammela, T., & Dow, L. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0190 · Cited by 257
Photodegradation of carbon dots cause cytotoxicity
Liu, Y., Yu, N., Fang, W., Tan, Q., Ji, R., Yang, L., Wei, S., Zhang, X., & Miao, A. (2021) · Nature Communications · doi:10.1038/s41467-021-21080-z · Cited by 255
A central role for cadherin signaling in cancer
Kourtidis, A., Lu, R., Pence, L. J., & Anastasiadis, P. Z. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.006 · Cited by 262
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207366 · Cited by 259
WNT Signaling in Cancer Immunosurveillance
Galluzzi, L., Spranger, S., Fuchs, E. V., & López‐Soto, A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.08.005 · Cited by 245
Wnt Signaling and Drug Resistance in Cancer
Zhong, Z., & Virshup, D. M. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.117978 · Cited by 243
Wnt signaling deregulation in the aging and Alzheimer’s brain
Palomer, E., Buechler, J., & Salinas, P. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00227 · Cited by 237
Scarth, J. A., Patterson, M. R., Morgan, E. L., & Macdonald, A. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001540 · Cited by 237
AKT and ERK dual inhibitors: The way forward?
Cao, Z., Liao, Q., Su, M., Huang, K., Jin, J., & Cao, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.025 · Cited by 244
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
Ang, H. L., Mohan, C. D., Shanmugam, M. K., Leong, H. C., Makvandi, P., Rangappa, K. S., Bishayee, A., Kumar, A. P., & Sethi, G. (2023) · Medicinal Research Reviews · doi:10.1002/med.21948 · Cited by 234
Genetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer
Rajamäki, K., Taira, A., Katainen, R., Välimäki, N., Kuosmanen, A., Plaketti, R.-M., Seppälä, T. T., Ahtiainen, M., Wirta, E.-V., Vartiainen, E., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.042 · Cited by 230
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Testa, U., Castelli, G., & Pelosi, E. (2020) · Medical Sciences · doi:10.3390/medsci8010018 · Cited by 238
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy
Tung, C., Hsu, Y., Shih, Y., Chang, P., & Lin, C. (2018) · Nephrology · doi:10.1111/nep.13451 · Cited by 225
Qin, K. H., Yu, M. S., Fan, J., Wang, H., Zhao, P., Zhao, G., Zeng, W., Chen, C., Wang, Y., Wang, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.030 · Cited by 243
Gajos-Michniewicz, A., & Czyż, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144852 · Cited by 230
Li, N., Kaur, P., Bunnag, N., Suresh, J., Sung, I. C. H., Tan, Q. H., Gruber, J., & Tolwinski, N. S. (2019) · Cells · doi:10.3390/cells8080826 · Cited by 228
Memariani, Z., Abbas, S. Q., Hassan, S. S. U., Ahmadi, A., & Chabra, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105264 · Cited by 219
The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Maruyama, K., & Imanaka‐Yoshida, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052617 · Cited by 225
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
Uddin, M. S., Mamun, A. A., Alghamdi, B. S. A., Tewari, D., Jeandet, P., Sarwar, M. S., & Ashraf, G. M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.015 · Cited by 224
Cancer, metastasis, and the epigenome
Kiri, S., & Ryba, T. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02069-w · Cited by 228
Zhang, Y., Song, J., Zhao, Z., Yang, M., Chen, M., Liu, C., Ji, J., & Zhu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.016 · Cited by 215
Mikubo, M., Inoue, Y., Liu, G., & Tsao, M. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.017 · Cited by 218
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
Schrörs, B., Boegel, S., Albrecht, C. H., Bukur, T., Bukur, V., Holtsträter, C., Ritzel, C., Manninen, K., Tadmor, A. D., Vormehr, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01195 · Cited by 215
TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer
Gough, N. R., Xiang, X., & Mishra, L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.064 · Cited by 208
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Al-Saafeen, B. H., Ali, B. R., & Elkord, E. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02212-7 · Cited by 226
Precision medicine for human cancers with Notch signaling dysregulation (Review)
Katoh, M., & Katoh, M. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4418 · Cited by 201
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Chelko, S. P., Asimaki, A., Lowenthal, J., Bueno-Beti, C., Bedja, D., Scalco, A., Amat-Alarcon, N., Andersen, P., Judge, D. P., Tung, L., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040676 · Cited by 192
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
Zhan, T., Ambrosi, G., Wandmacher, A. M., Rauscher, B., Betge, J., Rindtorff, N., Häussler, R. S., Hinsenkamp, I., Bamberg, L., Hessling, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09898-0 · Cited by 189
Self-citationMcDonald, M. M., Reagan, M. R., Youlten, S. E., Mohanty, S. T., Seckinger, A., Terry, R. L., Pettitt, J. A., Simic, M. K., Cheng, T. L., Morse, A., et al. (2017) · Blood · doi:10.1182/blood-2017-03-773341 · Cited by 186
CASTILHO, R. M., SQUARIZE, C. H., & Almeida, L. O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071506 · Cited by 187
Sexual Dimorphism in Colon Cancer
Abancens, M., Bustos, V., Harvey, H. M., McBryan, J., & Harvey, B. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.607909 · Cited by 194
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Chehelgerdi, M., Dehkordi, F. B., Chehelgerdi, M., Kabiri, H., Salehian-Dehkordi, H., Abdolvand, M. A., Salmanizadeh, S., Rashidi, M., Niazmand, A., Ahmadi, S., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01873-0 · Cited by 189
Rodon, J. A., Argilés, G., Connolly, R. M., Vaishampayan, U. N., de Jonge, M. J. A., Garralda, E., Giannakis, M., Smith, D. C., Dobson, J. R., McLaughlin, M. E., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01389-8 · Cited by 188
The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.
Juárez, M., Schcolnik‐Cabrera, A., & Dueñas‐González, A. (2018) · PubMed Central · Cited by 180
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Makena, M. R., Gatla, H. R., Verlekar, D. U., Sukhavasi, S., Pandey, M. K., & Pramanik, K. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174242 · Cited by 178
CD146, from a melanoma cell adhesion molecule to a signaling receptor
Wang, Z., Xu, Q., Zhang, N., Du, X., Xu, G., & Yan, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00259-8 · Cited by 189
Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy
Mahmoud, Y. K., & Abdelrazek, H. M. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108783 · Cited by 181
Wu, V. H., Yeerna, H., Nohata, N., Chiou, J., Harismendy, O., Raimondi, F., Inoue, A., Russell, R. B., Tamayo, P., & Gutkind, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.005601 · Cited by 185
Role of DNA Methylation in the Resistance to Therapy in Solid Tumors
Romero‐Garcia, S., Prado-Garcı́a, H., & Carlos‐Reyes, Á. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01152 · Cited by 176
GPCRs: Emerging anti-cancer drug targets
Nieto, A., & McDonald, P. H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.005 · Cited by 173
Inhibitors of the PD-1 Pathway in Tumor Therapy
LaFleur, M. W., Muroyama, Y., Drake, C. G., & Sharpe, A. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701044 · Cited by 180
Peng, Y., Xu, Y., Zhang, X., Deng, S., Yuan, Y., Luo, X., Hossain, M. T., Zhu, X., Du, K., Hu, F., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01457-w · Cited by 175
Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance
Makena, M. R., Ranjan, A., Thirumala, V., & Reddy, A. P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.015 · Cited by 173
Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers
Park, H., Kim, J.-W., & Baek, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113904 · Cited by 169
Chen, X., Yang, M., Yin, J., Li, P., Zeng, S., Zheng, G., He, Z., Liu, H., Wang, Q., Zhang, F., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00888-2 · Cited by 165
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Conway, J. R., Kofman, E., Mo, S. S., Elmarakeby, H., & Van Allen, E. (2018) · Genome Medicine · doi:10.1186/s13073-018-0605-7 · Cited by 165
Chu, X., Li, X., Zhang, Y., Dang, G., Miao, Y., Xu, W., Wang, J., Zhang, Z., & Cheng, S. (2024) · Nature Cancer · doi:10.1038/s43018-024-00807-z · Cited by 183
The role of ubiquitin-specific peptidases in cancer progression
Young, M.-J., Hsu, K., Lin, T. E., Chang, W., & Hung, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0522-0 · Cited by 165
Mechanisms of intercellular Wnt transport
Routledge, D., & Scholpp, S. (2019) · Development · doi:10.1242/dev.176073 · Cited by 146
Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Farooqı, A. A., de la Roche, M., Djamgoz, M. B. A., & Siddik, Z. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.001 · Cited by 158
Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer
Pasquereau-Kotula, E., Martins, M., Aymeric, L., & Dramsi, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00614 · Cited by 160
Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a
Dou, H., Shen, R., Tao, J., Huang, L., Shi, H., Chen, H., Wang, Y., & Wang, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00877 · Cited by 153
From instruction to output: Wnt/PCP signaling in development and cancer
Humphries, A. C., & Mlodzik, M. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.12.005 · Cited by 144
Gene Size Matters: An Analysis of Gene Length in the Human Genome
Lopes, I., Altab, G., Raina, P., & de Magalhães, J. P. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.559998 · Cited by 164
Fischer, M. M., Cancilla, B., Yeung, V. P., Cattaruzza, F., Chartier, C., Murriel, C. L., Cain, J., Tam, R., Cheng, C.-Y., Evans, J., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700090 · Cited by 154
Tam, B. Y. Y., Chiu, K., Chung, H., Bossard, C., Nguyen, J. D., Creger, E., Eastman, B. W., Mak, C. C., Ibanez, M., Ghias, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.009 · Cited by 154
Steenwinckel, J. V., Schang, A., Krishnan, M. L., Degos, V., Delahaye‐Duriez, A., Bokobza, C., Csaba, Z., Verdonk, F., Montané, A., Sigaut, S., et al. (2019) · Brain · doi:10.1093/brain/awz319 · Cited by 157
Emerging Roles of Wnt Ligands in Human Colorectal Cancer
Nie, X., Liu, H., Liu, L., Wang, Y., & Chen, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01341 · Cited by 156
Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
Jahanafrooz, Z., Mosafer, J., Akbari, M., Hashemzaei, M., Mokhtarzadeh, A., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29337 · Cited by 148
Bahrami, A., Amerizadeh, F., Shahidsales, S., Khazaei, M., Ghayour‐Mobarhan, M., Sadeghnia, H. R., Maftouh, M., Hassanian, S. M., & Avan, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25903 · Cited by 151
Kciuk, M., Alam, M., Ali, N., Rashid, S., Głowacka, P., Rajamanikandan, S., Çeli̇k, İ., Yahya, E. B., Dubey, A., Zerroug, E., et al. (2023) · Molecules · doi:10.3390/molecules28135246 · Cited by 148
Wu, X., Li, J., Gassa, A., Buchner, D., Alakus, H., Dong, Q., Ren, N., Liu, M., Odenthal, M., Stippel, D. L., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.44024 · Cited by 148
Metadata
- Authors
- Zhan, T., Rindtorff, N., & Boutros, M.
- Affiliations
- German Cancer Research Center (DE)
- Corresponding author
- Boutros, M
- Venue
- Oncogene
- Published
- 2016-09-12
- Volume
- 36
- Issue
- 11
- Pages
- 1461-1473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC5357762
- OpenAlex
- W2520632143
- Cited by
- 2,626
- References
- 213
- Citations by year
- 2026: 136 · 2025: 230 · 2024: 273 · 2023: 348 · 2022: 382 · 2021: 380 · 2020: 321 · 2019: 274 · 2018: 181 · 2017: 80 · 2016: 15
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Oncogene (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- Wnt signaling, carcinogenesis, colorectal cancer, cancer stem cells, metastasis, liquid tumors, stemness
- MeSH terms
- Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Humans, Mutation, Neoplasm Metastasis, Neoplasms, Protein Binding, Neoplastic Stem Cells, Tumor Escape, Wnt Proteins, beta Catenin, Molecular Targeted Therapy, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
